Penumbra Inc (NYSE:PEN)
| 244.91 Delayed Data As of Jan 26 |  +0.33 / +0.13%Today’s Change | 114.87 Today|||52-Week Range 253.22 | +10.09% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $9.4B |
Company Description
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. Its target markets include interventional neuroradiologists, neurosurgeons, neurologists, cardiologists, radiologists, and vascular surgeons. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Contact Information
Penumbra, Inc. One Penumbra Place Alameda California 94502 |
Employees
Shareholders
| Mutual fund holders | 64.93% |
| Other institutional | 19.11% |
| Individual stakeholders | 10.70% |
Top Executives
| Adam Elsesser | Chairman, President & Chief Executive Officer |
| Ben Sorci | Executive Vice President-Operations |
| Maggie S. Yuen | Chief Financial Officer |
| Pankaj Tiwari | Chief Information Officer & Executive VP |
| Michaella Corso | Vice President-Clinical Affairs |
